Early research (Phase 1)Study completedNCT01380249What this trial is testingPDM08 Clinical Trial in Advanced Solid TumorsWho this might be right forMalignant Solid Tumours Prodimed S.A. 22
Early research (Phase 1)Looking for participantsNCT07281326What this trial is testingAK138D1 in Advanced Malignant TumorsWho this might be right forSolid Cancer Akeso 200
Testing effectiveness (Phase 2)Looking for participantsNCT06750185What this trial is testingSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 248
Early research (Phase 1)Ended earlyNCT05228015What this trial is testingOral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid TumorsWho this might be right forSolid Tumors, AdultSolid TumorMalignant Pleural Mesothelioma (MPM)+5 more Ikena Oncology 67
Early research (Phase 1)Study completedNCT02227940What this trial is testingCeritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic CancerWho this might be right forAdvanced Malignant Solid NeoplasmALK PositiveMetastatic Pancreatic Adenocarcinoma+2 more Roswell Park Cancer Institute 38
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00195260What this trial is testingStudy Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid TumorsWho this might be right forNeoplasms Pfizer 151
Early research (Phase 1)WithdrawnNCT03920839What this trial is testingINCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)Who this might be right forAdvanced and/or Metastatic Solid TumorsStage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung CancerAdvanced/Metastatic Unresectable Malignant Pleural Mesothelioma Incyte Corporation
Testing effectiveness (Phase 2)Active Not RecruitingNCT06385496What this trial is testingTesting MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic Changes (MATCH - Subprotocol L)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT03590054What this trial is testingAbexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesWho this might be right forStage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more Rahul Aggarwal 35
Early research (Phase 1)UnknownNCT05315180What this trial is testingA Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid TumorsWho this might be right forMalignant NeoplasmsMetastatic Cancer Betta Pharmaceuticals Co., Ltd. 80
Early research (Phase 1)Study completedNCT00551096What this trial is testingGemcitabine/Capecitabine/ZD6474 in Advanced Solid TumorsWho this might be right forMalignant Solid TumourBiliary CancerPancreatic Cancer University of Colorado, Denver 23
Very early researchWithdrawnNCT05238831What this trial is testingSMMART Adaptive Clinical Treatment (ACT) TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+14 more OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06643754What this trial is testingA Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant TumorsWho this might be right forAdvanced Solid Tumors Suzhou Suncadia Biopharmaceuticals Co., Ltd. 115
Early research (Phase 1)Study completedNCT03784677What this trial is testingA Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more M.D. Anderson Cancer Center 11
Early research (Phase 1)Study completedNCT00884845What this trial is testingTrial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors PharmaMar 35
Early research (Phase 1)Ended earlyNCT00088647What this trial is testingStudy Evaluating MST-997 in Advanced Malignant Solid TumorsWho this might be right forNeoplasms Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)UnknownNCT05564858What this trial is testingFDA022-BB05 in Subjects With Advanced Solid Malignant TumorsWho this might be right forAdvanced Solid Tumors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 107
Early research (Phase 1)Active Not RecruitingNCT04704661What this trial is testingTesting the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialWho this might be right forAdvanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209